External

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

iPSC Seminars: Early Drug Discovery Unit (EDDU)

admin — Thu, 31 Jul 2025 15:32:34 +0000

THE NEURO'S EDDU iPSC SEMINAR SERIES

Modeling α-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Memory Disorders Research Society: Annual Meeting 2025

admin — Mon, 26 Aug 2024 16:01:33 +0000

Memory Disorders Research Society (MDRS) is a professional society dedicated to the study of memory. Members engage in basic and clinical research into how memory works and why it fails.

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

admin — Tue, 05 Aug 2025 17:49:37 +0000

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research.

Exhibit | ouch ouch ouch

admin — Thu, 13 Mar 2025 12:49:12 +0000

La version française suit.

91�� Healthcare-Management Case Competition (MHCC) - Date TBD

admin — Thu, 27 Mar 2025 20:14:22 +0000

GCHM and IMHL students and alumni - apply your knowledge in a real-world healthcare challenge.

Save the Date: Department of Medicine Annual Awards Soirée

admin — Tue, 25 Mar 2025 17:18:45 +0000

Join us on Thursday, September 18, 2025, from 6 PM to 10 PM, at the Passerelle-Perspective in Montreal’s Old Port for a memorable evening honouring the achievements of our faculty and residents.

Amazing Brain Science Talks 2025

admin — Tue, 08 Jul 2025 15:23:33 +0000

Join us for a day dedicated to YOUR amazing brain!

New tool helps seniors reduce unnecessary medications

admin — Mon, 04 Aug 2025 13:09:12 +0000

91�� researchers have developed and are licensing a digital tool to help safely reduce patients’ use of medications that may be unnecessary or even harmful to them.

When clinicians review a patient’s file, MedSafer flags potentially inappropriate medications. In a new clinical trial, the software helped deprescribe such medications in 36 per cent of long-term care residents, nearly triple as many as when reviews were done without the tool.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.